TLR9 and idiopathic pulmonary fibrosis: While those experiments were conducted with CPG ODN rather than mtDNA as a TLR9 agonist, our findings that show that mtDNA derived from PINK1-depleted AECII can be a more effective driver of fibroblast activation in the progression of IPF.